secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001564590-22-018244
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen Q1 2022 revenue down 7.5% YoY to $80.4M; net loss $0.62 per share
------------------------------------------------------------------------

- GAAP net loss $14.2M ($0.62/share); adjusted loss per share $0.39.
- Revenue $80.4M, down 7.5% YoY, up 5.2% sequentially; domestic B2B fell 83.4% to $5.1M.
- Gross margin declined 240 bps to 43.5% due to higher materials costs and temporary manufacturing shutdown.
- No FY2022 revenue guidance; Q2 revenue expected to improve sequentially and be in line with Q2 2021; expects continued losses.
- EU MDR submission for portable oxygen concentrators filed and under review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000156459022018244/0001564590-22-018244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000156459022018244/ingn-8k_20220505.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-018244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer